FibroBiologics terminated its sublease early, saving approximately $0.8 million in future rent payments and consolidating operations into its new laboratory facility.
Key takeaways
The company entered into a Lease Termination Agreement on April 3, 2026, ending its sublease effective April 2, 2026.
The sublease was originally set to expire on November 30, 2027, so termination occurred approximately 18 months ahead of schedule.
The company made a single payment of $45,108.25 to resolve remaining rent obligations.
The termination is expected to save approximately $0.8 million in future rent payments.
This move follows the 2025 opening of the company's new state-of-the-art laboratory facility.
The company's principal executive offices have been relocated to 9350 Kirby Drive, Suite 300, Houston, Texas 77054.